The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung
- PMID: 26696594
- PMCID: PMC11819316
- DOI: 10.1007/s00432-015-2098-8
The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung
Abstract
Purpose: Histological vascular invasion (VI) is major predictor of recurrence after surgery for several cancer types. We previously reported that VI with abundant stromal cell infiltrates was a negative prognostic factor in lung adenocarcinoma. This study examined whether stromal cell infiltrates within VI are associated with prognosis in high-grade neuroendocrine carcinoma (HGNEC) of the lung.
Methods: We investigated the relationship between the frequency and density of VI and recurrence-free survival (RFS) of 60 resected HGNEC patients without adjuvant chemotherapy. We examined prognostic effects of CD204 (+) macrophages, CD34 (+) microvessels and α-smooth muscle actin (+) myofibroblasts within VI. Correlation between expressions of stem cell-related molecules (ALDH-1, Notch 1, CD44) and epithelial-mesenchymal transition-related molecules (E-cadherin, S100A4) in cancer cells within VI and RFS was also analyzed.
Results: Among 60 cases, 51 cases showed VI. Although the presence of VI was a significant predictor for worse RFS (P = 0.04), the frequency and density of VI were not correlated with RFS. The number of CD204 (+) macrophage, CD34 (+) microvessels and α-smooth muscle actin (+) myofibroblasts within VI did not influence on the RFS. On the contrary, cases with higher Notch 1 expression in cancer cells in the VI displayed significantly shorter RFS than lower expression group (7.6 vs. 29.4 months, P = 0.02).
Conclusions: The current study revealed the presence of stromal cells within VI was not significant predictor for recurrence in HGNEC. This suggests that in HGNEC, unlike adenocarcinoma, intravascular stromal cells are not major contributors to metastasis.
Keywords: High-grade neuroendocrine carcinoma; Intravascular microenvironment; Large cell neuroendocrine carcinoma; Notch1; Small cell lung cancer; Stromal cells; Vascular invasion.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures




Similar articles
-
Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma.J Cancer Res Clin Oncol. 2016 Mar;142(3):593-600. doi: 10.1007/s00432-015-2068-1. Epub 2015 Oct 31. J Cancer Res Clin Oncol. 2016. PMID: 26521256 Free PMC article.
-
Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.J Cancer Res Clin Oncol. 2015 Dec;141(12):2121-30. doi: 10.1007/s00432-015-1985-3. Epub 2015 May 12. J Cancer Res Clin Oncol. 2015. PMID: 25963795 Free PMC article.
-
Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung.J Cancer Res Clin Oncol. 2013 Nov;139(11):1869-78. doi: 10.1007/s00432-013-1502-5. Epub 2013 Sep 7. J Cancer Res Clin Oncol. 2013. PMID: 24013219 Free PMC article.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
Cited by
-
Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?Front Endocrinol (Lausanne). 2021 Jul 22;12:672499. doi: 10.3389/fendo.2021.672499. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34367064 Free PMC article. Review.
-
Overexpression of α-sma-positive fibroblasts (CAFs) in Nasopharyngeal Carcinoma Predicts Poor Prognosis.J Cancer. 2017 Oct 23;8(18):3897-3902. doi: 10.7150/jca.20324. eCollection 2017. J Cancer. 2017. PMID: 29151978 Free PMC article.
References
-
- Asamura H, Kameya T, Matsuno Y, Noguchi M, Tada H, Ishikawa Y, Yokose T, Jiang SX, Inoue T, Nakagawa K, Tajima K, Nagai K (2006) Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 24:70–76 - PubMed
-
- Fischer M, Yen WC, Kapoun AM, Wang M, O’Young G, Lewicki J, Gurney A, Hoey T (2011) Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations. Cancer Res 71:1520–1525 - PubMed
-
- Hassan WA, Yoshida R, Kudoh S, Hasegawa K, Niimori-Kita K, Ito T (2014) Notch1 controls cell invasion and metastasis in small cell lung carcinoma cell lines. Lung Cancer 86:304–310 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous